2024
|
Invention
|
Modulators of g-protein coupled receptors.
This disclosure features chemical entities (e.g., a c... |
|
Invention
|
Synthesis of glp-1r/gipr agonists and precursors thereof. The present disclosure provides a novel... |
|
Invention
|
Treatment of adults with overweight or obesity with or without weight-related comorbidities. The ... |
|
Invention
|
Treatment of adults with overweight or obesity with or without weight-related comorbidities.
The... |
|
Invention
|
Treatment of diabetes mellitus.
The present disclosure provides methods and compositions for tre... |
|
Invention
|
Treatment of diabetes mellitus. The present disclosure provides methods and compositions for trea... |
2023
|
Invention
|
N-heterocylic gpcr receptor agonists, pharmaceutical compositions comprising the same, and method... |
2022
|
Invention
|
Oxazole, oxadiazole, and indole derivatives for the inhibition of usp28.
Provided herein are USP... |
|
Invention
|
Oxazole, oxadiazole, and indole derivatives for the inhibition of usp28. Provided herein are USP2... |
|
Invention
|
Modulators of g-protein coupled receptors. This disclosure features chemical entities (e.g., a co... |
|
Invention
|
Benzimidazoyl glp-1 receptor agonists, pharmaceutical compositions comprising the same, and metho... |
|
Invention
|
Gpcr receptor agonists, pharmaceutical compositions comprising the same, and methods for their us... |
2019
|
Invention
|
N-cyano-7-azanorbornane derivatives and uses thereof. The present invention provides a compound o... |
2009
|
Invention
|
Methods of chemotype evolution. Herein is described a method to rapidly screen a large chemical s... |